Development of DNA Vaccine Candidate against SARS-CoV-2
Despite the existence of various types of vaccines and the involvement of the world’s leading pharmaceutical companies, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) remains the most challenging health threat in this century. Along with the increased transmissibility, new strains cont...
Main Authors: | Xingyun Wang, Nino Rcheulishvili, Jie Cai, Cong Liu, Fengfei Xie, Xing Hu, Nuo Yang, Mengqi Hou, Dimitri Papukashvili, Yunjiao He, Peng George Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-05-01
|
Series: | Viruses |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4915/14/5/1049 |
Similar Items
-
Development of an LNP-Encapsulated mRNA-RBD Vaccine against SARS-CoV-2 and Its Variants
by: Cong Liu, et al.
Published: (2022-05-01) -
Strategy of developing nucleic acid-based universal monkeypox vaccine candidates
by: Dimitri Papukashvili, et al.
Published: (2022-10-01) -
Design, evaluation, and immune simulation of potentially universal multi-epitope mpox vaccine candidate: focus on DNA vaccine
by: Nino Rcheulishvili, et al.
Published: (2023-07-01) -
Strong immune responses and protection of PcrV and OprF-I mRNA vaccine candidates against Pseudomonas aeruginosa
by: Xingyun Wang, et al.
Published: (2023-05-01) -
Identification of Tumor Antigens and Design of mRNA Vaccine for Colorectal Cancer Based on the Immune Subtype
by: Cong Liu, et al.
Published: (2022-01-01)